Determining The Origin Of Lethal Metastases In Multifocal Primary Prostate Cancer
Grant number: 1047581 | Funding period: 2013 - 2016
New biomarkers are required to accurately predict lethal prostate cancer from benign, indolent disaese that doesn't require expensive treatment. To do this relies on finding molecular differences between disease states. Advancements in high throughput genomic technologies enables us to now probe the lethal prostate cancer genome and transcriptome and distinguish this disease state from other forms of prostate cancer.
Related publications (4)
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
Matthew KH Hong, Geoff Macintyre, David C Wedge, Peter Van Loo, Keval Patel, Sebastian Lunke, Ludmil B Alexandrov, Clare Sloggett, Marek Cmero, Francesco Marass, Dana Tsui, Stefano Mangiola, Andrew Lonie, Haroon Naeem, Nikhil Sapre, Pramit M Phal, Natalie Kurganovs, Xiaowen Chin, Michael Kerger, Anne Y Warren
Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array
Haroon Naeem, Nicholas C Wong, Zac Chatterton, Matthew KH Hong, John S Pedersen, Niall M Corcoran, Christopher M Hovens, Geoff Macintyre